openPR Logo
Press release

Growing Respiratory Disease Fuel Rise in Chronic Rhinosinusitis Market: Key Factor Driving The Growth In The Chronic Rhinosinusitis With Nasal Polyps Market

05-26-2025 11:34 AM CET | Health & Medicine

Press release from: The Business Research Company

Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps

The Chronic Rhinosinusitis With Nasal Polyps Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Chronic Rhinosinusitis With Nasal Polyps Market Size During the Forecast Period?
The chronic rhinosinusitis with nasal polyps market size has grown strongly in recent years. It will increase from $4.02 billion in 2024 to $4.4 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. The growth is due to the increasing prevalence of the condition, advancements in diagnosis and treatment, increased patient awareness, and growing healthcare spending.

The chronic rhinosinusitis with nasal polyps market is expected to reach $6.21 billion by 2029, growing at a CAGR of 9.0%. The growth is attributed to the rise of biologic therapies, personalized medicine, technological advancements, regulatory approvals, patient-centered care, and epidemiological trends. Key trends include innovative drug delivery systems, pathophysiology understanding, clinical trials, longitudinal studies, and integrated care models.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17113

What Are the High-Growth Segments in the Chronic Rhinosinusitis With Nasal Polyps Market?
The chronic rhinosinusitis with nasal polyps market covered in this report is segmented -

1) By Treatment: Medications, Surgical Methods
2) By Route Of Administration: Nasal, Oral, Other Routes Of Administration
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Medications: Corticosteroids (Nasal Sprays, Oral Steroids), Biologics (Monoclonal Antibodies Like Dupilumab), Antibiotics, Antihistamines, Leukotriene Modifiers
2) By Surgical Methods: Endoscopic Sinus Surgery (ESS), Polypectomy (Polyps Removal), Balloon Sinuplasty

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17113&type=smp

What Key Drivers Are Expected to Influence Future Chronic Rhinosinusitis With Nasal Polyps Market Growth?
The increasing prevalence of respiratory diseases is expected to propel the growth of the chronic rhinosinusitis with nasal polyps (CRSwNP) market. Respiratory diseases like asthma and COPD are linked to an increase in CRSwNP, which creates a demand for diagnostic tools and treatments. According to the National Center for Health Statistics, asthma prevalence in the U.S. increased in 2022, leading to more cases of related conditions like CRSwNP. Therefore, the rise in respiratory diseases will drive the CRSwNP market.

Which Companies Hold the Largest Share Across Different Chronic Rhinosinusitis With Nasal Polyps Market Segments?
Major companies operating in the chronic rhinosinusitis with nasal polyps market are Pfizer Inc., Roche Holding AG, Merck & Co Inc, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Medtronic plc, Boehringer Ingelheim International GmbH, Amgen Inc, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc, Daiichi Sankyo Company Limited, Olympus Corporation, Eisai Co Ltd, Smith & Nephew PLC, Genentech USA Inc, Mallinckrodt Pharmaceuticals, Lyra Therapeutics Inc, Sunovion Pharmaceuticals, Acclarent Inc., Optinose US Inc, SinuSys Corporation, Biohaven Pharmaceuticals

What Are the Major Trends Shaping the Chronic Rhinosinusitis With Nasal Polyps Market?
Companies in the chronic rhinosinusitis with nasal polyps market are focusing on biologics such as anti-IL-5 therapies to improve patient outcomes. For example, in March 2024, Optinose, a US-based pharmaceutical company, received FDA approval for its XHANCE nasal spray. This spray uses a unique Exhalation Delivery System (EDS) to enhance medication delivery deep into the nasal passages, treating chronic rhinosinusitis with nasal polyps and improving patient outcomes.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/chronic-rhinosinusitis-with-nasal-polyps-global-market-report

What Are the Emerging Geographies for The Chronic Rhinosinusitis With Nasal Polyps Market Growth?
North America was the largest region in the chronic rhinosinusitis with nasal polyps market in 2023. The regions covered in the chronic rhinosinusitis with nasal polyps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Chronic Rhinosinusitis With Nasal Polyps Market?
2. What is the CAGR expected in the Chronic Rhinosinusitis With Nasal Polyps Market?
3. What Are the Key Innovations Transforming the Chronic Rhinosinusitis With Nasal Polyps Industry?
4. Which Region Is Leading the Chronic Rhinosinusitis With Nasal Polyps Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Growing Respiratory Disease Fuel Rise in Chronic Rhinosinusitis Market: Key Factor Driving The Growth In The Chronic Rhinosinusitis With Nasal Polyps Market here

News-ID: 4035669 • Views:

More Releases from The Business Research Company

Strong Growth Ahead: Elder Care Assistive Robots Market Size To Grow At Arecord 16.5% Cagr By 2029
Strong Growth Ahead: Elder Care Assistive Robots Market Size To Grow At Arecord …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. How Big Is the Elder Care Assistive Robots Market Size Expected to Be by 2034? The market size for elder care assistive robots has experienced a fast-paced growth over the recent past. The expectation is for it to rise from a recorded $2.98 billion in 2024 to a projected $3.49 billion come 2025, a
Emerging Trends Influencing The Growth Of The Distillers Dried Grains With Solubles Market: Grain-Based Ethanol Innovations Driving Growth In The Distillers Dried Grains with Solubles Market
Emerging Trends Influencing The Growth Of The Distillers Dried Grains With Solub …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. How Big Is the Distillers Dried Grains With Solubles Market Size Expected to Be by 2034? In recent years, the market for distillers dried grains with solubles has witnessed robust growth. An escalation from $12.45 billion in 2024 to $13.39 billion in 2025 is anticipated, reflecting a compound annual growth rate (CAGR) of 7.6%.
Global Digital Insomnia Therapeutics Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities
Global Digital Insomnia Therapeutics Market Analysis 2025-2030: Growth Drivers, …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. How Big Is the Digital Insomnia Therapeutics Market Size Expected to Be by 2034? Over the past few years, the digital insomnia therapeutics market has experienced significant expansion. The size of this market is projected to increase from $3.27 billion in 2024 to $3.49 billion in 2025, showcasing a compound annual growth rate (CAGR)
Strong Growth Ahead: Dengue Treatment Market Size To Grow At Arecord 11.6% Cagr By 2029
Strong Growth Ahead: Dengue Treatment Market Size To Grow At Arecord 11.6% Cagr …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. How Big Is the Dengue Treatment Market Size Expected to Be by 2034? The market for dengue treatment has experienced rapid expansion in the last few years. The market size is expected to scale up from $2.10 billion in 2024 to $2.35 billion in 2025, with a compound annual growth rate (CAGR) of 12.0%.

All 5 Releases


More Releases for Nasal

Hiloi Nasal Strips Review 2022: (Must Have!) Hiloi Nasal Strips Must have for ev …
Sleeping next to someone who snores is challenging. This has been a major difficulty in many relationships and marriages, according to the majority of people. This has recently risen to the top of the list of reasons for divorce. When one partner snores all night, the other is unable to get a good night's sleep, which leads to countless arguments, disagreements, and problems. If your spouse snores, it might strain your relationship
Infant Nasal Cannula Market Suppliers, Region, Type, Growth Factors, Demand and …
The Global Infant Nasal Cannula Market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Infant Nasal Cannula market. Analysts have
Global Nasal Cannulas Market Research Report
This report studies the global Nasal Cannulas market status and forecast, categorizes the global Nasal Cannulas market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Medtronic BD Salter Labs Teleflex Westmed Smiths Medical Flexicare A-M Systems Intersurgical Geographically, this report studies the
Nasal Drug Delivery Systems Market Report 2018: Segmentation by Dosage Form (Nas …
Global Nasal Drug Delivery Systems market research report provides company profile for Merck & Co., GlaxoSmithKline plc, AstraZeneca plc, Johnson & Johnson, Pfizer Inc., Baxter International, Inc., Valeant Pharmaceuticals International, Inc., Becton, Dickinson and Company, Novartis AG and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Nasal Aspirator Market
Nasal aspirator is a small medical device which is used to clear the nose of a baby. When babies suffered from cold, the snot (nasal mucus) develop in their nose. Unfortunately, babies do not know how to blow their nose to clear, nasal aspirators, however, work effectively in clearing up their stuffy nose and give them immediate relief from breathlessness. A nasal respirator is cheap and is easy to use.
Absorbable Nasal Implant Devices Market
Absorbable nasal implants are used to treat nasal blockage or obstructions and allow better breathing and sleep to the patient. Nasal airway obstruction can be caused by several factors, including septal deviation, enlarged turbinates, and weakened upper and/or lower lateral nasal wall cartilage, which can lead to nasal valve collapse (vestibular stenosis). Symptoms include stuffiness, congestion or an inability to breathe through one or both nostrils. The nasal valve